Adenovirus-mediated overexpression of novel mutated IκBα inhibits nuclear factor κB activation in endothelial cells

Chinese Medical Journal

Volumn 118, Issue 17, 2005, Pages 1422-1428

  Zhou, Lin Fu ^a   Yin, Kai Sheng ^a   Zhu, Zi Lu ^a   Zhu, Yi ^a   Yao, Xin ^a   Mao, Hui ^a   Xie, Wei Ping ^a   Huang, Mao ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Asthma; Gene therapy; I B mutant; Nuclear factor B; Recombinant adenovirus

Indexed keywords

ADENOVIRUS VECTOR; AMINO ACID; COMPLEMENTARY DNA; DNA; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOFECTAMINE; NUCLEOTIDE; PHORBOL 13 ACETATE 12 MYRISTATE; POLYADENYLIC ACID; SERINE;

AMINO TERMINAL SEQUENCE; ARTICLE; ASTHMA; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA SEQUENCE; ENDOTHELIUM CELL; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE INSERTION; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; MOLECULAR CLONING; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RESPIRATORY TRACT INFLAMMATION; RESTRICTION MAPPING; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; VIRUS REPLICATION; WESTERN BLOTTING;

ADENOVIRIDAE; CELL LINE; ENDOTHELIAL CELLS; GENE THERAPY; HUMANS; I-KAPPA B PROTEINS; MUTATION; NF-KAPPA B; TETRADECANOYLPHORBOL ACETATE;

EID: 25844432173     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Zhou LF, Yin KS. Toll-like receptors: function and roles in asthma. Chin Med J 2004;117:1709-1715.
2. Cogswell PC, Kashatus DF, Keifer JA, et al. NF-κB and IκBα are found in the mitochondria: evidence for regulation of mitochondrial gene expression by NF-κB. J Biol Chem 2003; 278:2963-2968.
3. Hoffmann A, Levchenko A, Scott ML, et al. The IκB-NF-κB signaling module: temporal control and selective gene activation. Science 2002;298:1241-1245.
4. Zhu ZL, Wang RN, Shen Q, et al. Cloning of IκBα gene and construction of its eukaryotic expression vector. Acta Nanjing Med Univ (Chin) 2002;22:130-131.
5. Lentsch AB, Jordan JA, Czermak BJ, et al. Inhibition of NF-κB activation and augmentation of IκBβ by secretory leukocyte protease inhibitor during lung inflammation. Am J Pathol 1999;154:239-247.
6. Jeong DW, Yook MH, Kim TS, et al. Protection of mice from allergen-induced asthma by selenite: prevention of eosinophil infiltration by inhibition of NF-κB activation. J Biol Chem 2002;277:17871-17876.
7. Zhou LF, Yin KS, Zhu ZL, et al. Inhibition of nuclear factor κB activation through induction of IκBα expression by arsenic trioxide in a murine model of asthma. Respirology 2004;9 Suppl:A94.
8. Zhou LF, Yin KS. Inhibition of nuclear factor κB overexpression by arsenic trioxide contributes to eosinophil apoptosis in asthmatic guinea-pigs. Chin J Tuberc Respir Dis (Chin) 2002;25:439.
9. Poynter ME, Cloots R, van Woerkom T, et al. NF-κB activation in airways modulates allergic inflammation but not hyperresponsiveness. J Immunol 2004;173:7003-7009.
10. Wright JG, Christman JW. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy. Am J Respir Med 2003;2:211-219.
11. Barnes PJ. New directions in allergic diseases: mechanism-based anti-inflammatory therapies. J Allergy Clin Immunol 2000;106:5-16.
12. Castro-Alcaraz S, Miskolci V, Kalasapudi B, et al. NF-κB regulation in human neutrophils by nuclear IκBα: correlation to apoptosis. J Immunol 2002;169:3947-3953.
13. Jobin C, Panjia A, Hellerbrand C, et al. Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor κB super-repressor in human intestinal epithelial cells. J Immunol 1998;160:410-418.
14. Wang CY, Mayo MW, Korneluk RG, et al. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998;281:1680-1683.
15. Liu BR, Huang AL, Shen DM. Cloning and sequence analysis of Chinese IκBα gene. Immunol J (Chin) 2002;18:81-84.
16. West J, Rodman DM. Gene therapy for pulmonary diseases. Chest 2001;119:613-617.
17. Graham FL. Adenovius vectors for high-efficiency gene transfer into mammalian cells. Immunol Today 2000; 21:426-428.
18. Bowen GP, Borgland SL, Lam M, et al. Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-κB. Hum Gene Ther 2002;13:367-379.
19. Factor P. Gene therapy for asthma. Mol Ther 2003;7: 148-152.
20. Jain VV, Kitagaki K, Kline JN. CpG DNA and immunotherapy of allergic diseases. Clin Exp Allergy 2003;33:1330-1335.
21. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J Clin Invst 2001;107:131-141.
22. ATP channel opener, on pulmonary vascular remodeling in hypoxic rats. Life Sci 2004;75:2065-2076.